@article {47, editor = {,}, title = {Cephradine}, volume = {11}, number = {12}, pages = {47--47}, year = {1973}, doi = {10.1136/dtb.11.12.47}, publisher = {British Medical Journal Publishing Group}, abstract = {Cephradine (Eskacef - SKF; Velosef - Squibb) is a new semi-synthetic cephalosporin for oral use. Like other cephalosporins it is active against both Gram-negative and Gram-positive pathogens, apparently including penicillinase-producing staphylococci (though this has been questioned1). It is advertised as having {\textquoteleft}new striking power{\textquoteright}, but from the data provided its spectrum of activity closely resembles that of cephalexin (Ceporex - Glaxo; Keflex - Lilly),2 and the promotional literature on cephradine makes no direct comparison between the two drugs.}, issn = {0012-6543}, URL = {https://dtb.bmj.com/content/11/12/47}, eprint = {https://dtb.bmj.com/content/11/12/47.full.pdf}, journal = {Drug and Therapeutics Bulletin} }